Pharma and Biotech M&A Boom Accelerates as Companies Expand PipelinesZacks Investment Research • 06/11/26
I Would Rebuild My Portfolio With Just These 3 Stocks If I Lost Everything Tomorrow24/7 Wall Street • 06/10/26
Eli Lilly Wins FDA Nod for Extended Ebglyss Dosing in Eczema CareZacks Investment Research • 06/10/26
Eli Lilly and Company (LLY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 TranscriptSeeking Alpha • 06/09/26
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitisPRNewsWire • 06/09/26
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive PlayInvestopedia • 06/09/26
Can Eli Lilly's Clinical Momentum Keep the Stock at Record Highs?Zacks Investment Research • 06/09/26
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next StrikeZacks Investment Research • 06/09/26
Forget Nvidia and SpaceX. This 150-Year-Old Indiana Company Could Become the World's Largest in 5 Years24/7 Wall Street • 06/09/26
Convatec and Lilly Foundation Commit $5m to Partners In Health to Improve Care for Non‑communicable Disease and Chronic ConditionsBusiness Wire • 06/09/26
The space race is coming for pharma: Why drug development is heading to lower Earth orbitCNBC • 06/09/26
Prediction: The Trump Bull Market Will Soon End -- But These 2 Stocks Will Keep Winning AnywayThe Motley Fool • 06/08/26
Lilly Just Announced 3 Infectious Disease Acquisitions in 1 Day. Is This the Beginning of Its Post-Obesity Growth Strategy?The Motley Fool • 06/08/26